FTC

CSPI Asks the FDA and FTC to Take Enforcement Action

FTC Considers Similar Endorsements by Non-Medical “Doctors” Deceptive

Warning Letters Follow CSPI Investigation and Request for Enforcement Action

New Investigative Report Finds Slotting Fees, “Category Captains,” and Other Deals Undermine Consumer Choice

Statement by CSPI Regulatory Affairs Director Laura MacCleery

Statement of CSPI Nutrition Policy Director Margo G. Wootan

CSPI Recommends Consumers Avoid Product Pending FDA Investigation into Deaths